Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease
Clinical trial NCT04189432 · UNKNOWN
Trial details
- NCT number
- NCT04189432
- Sponsor
- SCM Lifescience Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-28
- Primary completion
- 2024-03-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.